Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MelixGX is a consumer health and genetics company that marketed direct-to-consumer DNA testing kits focused on how an individual's genetics may influence response to cannabis and, historically, broader wellness and fitness traits. The company appears to have operated primarily through at-home buccal-swab collection kits and third-party laboratory analysis, returning personalized reports on cannabis-related genetic insights and product-use guidance. Publicly available evidence points to a small private company based in West Palm Beach, Florida, founded in 2018. Business-directory and corporate-registry sources indicate the Florida legal entity is now inactive, although the brand website has remained accessible. MelixGX does not appear to be a therapeutics developer and there is no evidence of a traditional drug pipeline or clinical-stage pharmaceutical programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MelixGX.